Showing results (81-90 of 89) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Experimental Gerontology|September 15, 2012
Low plasma DHEA-S increases mortality risk among male hemodialysis patientsHeng-Jung Hsu, Chiung-Hui Yen, Chih-Ken Chen, et al.BMC Nephrology|January 10, 2014
Factors associated with chronic musculoskeletal pain in patients with chronic kidney diseaseHeng-Jung Hsu, Chiung-Hui Yen, Kuang-Hung Hsu, et al.International Journal of Biological Sciences|February 5, 2020
Gut Microbiota as Diagnostic Tools for Mirroring Disease Progression and Circulating Nephrotoxin Levels in Chronic Kidney Disease: Discovery and Validation StudyI-Wen Wu, Chan-Yu Lin, Lun-Ching Chang, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 8, 2011
Association between cold dialysis and cardiovascular survival in hemodialysis patientsHeng-Jung Hsu, Chiung-Hui Yen, Kuang-Hung Hsu, et al.Healthcare (Basel, Switzerland)|September 28, 2021
Effective Preventive Strategies to Prevent Secondary Transmission of COVID-19 in Hemodialysis Unit: The First Month of Community Outbreak in TaiwanChun-Yu Chen, Jung-Jr Ye, Ting-Shuo Huang, et al.NPJ Digital Medicine|November 3, 2022
Discovering a trans-omics biomarker signature that predisposes high risk diabetic patients to diabetic kidney diseaseI-Wen Wu, Tsung-Hsien Tsai, Chi-Jen Lo, et al.Journal of the Chinese Medical Association : JCMA|December 15, 2025
Efficacy, safety, and immunogenicity of UB-851 versus Eprex® in patients with renal anemia receiving hemodialysis: A randomized, double-masked, phase III trialChien-Hsing Wu, Chih-Chung Shiao, Hsien-Yi Wang, et al.Gut Microbes|March 6, 2025
Machine-learning assisted discovery unveils novel interplay between gut microbiota and host metabolic disturbance in diabetic kidney diseaseI-Wen Wu, Yu-Chieh Liao, Tsung-Hsien Tsai, et al.Nephrology (Carlton, Vic.)|May 15, 2025
Non-Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol-Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 TrialSimon D Roger, Chew Ming Wong, Phisitt Vejakama, et al.Pageof 9